Health Catalyst, Inc. Segments Disclosure
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
Adjusted Gross Profit: | |||||||||||||||||
Technology | $ | 140,315 | $ | 129,139 | $ | 127,339 | |||||||||||
Professional Services | 18,792 | 20,394 | 15,099 | ||||||||||||||
Total reportable segments Adjusted Gross Profit | 159,107 | 149,533 | 142,438 | ||||||||||||||
Less Adjusted Gross Profit reconciling items: | |||||||||||||||||
Stock-based compensation | (4,475) | (7,741) | (9,235) | ||||||||||||||
Acquisition-related costs, net(3) | (328) | (753) | (664) | ||||||||||||||
| Restructuring costs | (2,629) | (260) | (706) | ||||||||||||||
Less other reconciling items: | |||||||||||||||||
Sales and marketing | (52,477) | (54,387) | (67,321) | ||||||||||||||
Research and development | (49,770) | (57,950) | (72,627) | ||||||||||||||
| General and administrative | (49,559) | (56,817) | (76,559) | ||||||||||||||
Depreciation and amortization | (50,500) | (41,431) | (42,223) | ||||||||||||||
Impairment of goodwill and intangible assets | (110,223) | — | — | ||||||||||||||
| Interest and other income (expense), net | (16,404) | 637 | 9,106 | ||||||||||||||
| Loss before income taxes | $ | (177,258) | $ | (69,169) | $ | (117,791) | |||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
Technology: | |||||||||||||||||
Revenue | $ | 208,277 | $ | 194,852 | $ | 187,583 | |||||||||||
Adjusted Cost of Revenue(1) | 67,962 | 65,713 | 60,244 | ||||||||||||||
Adjusted Gross Profit | $ | 140,315 | $ | 129,139 | $ | 127,339 | |||||||||||
Professional Services: | |||||||||||||||||
Revenue | $ | 102,859 | $ | 111,732 | $ | 108,355 | |||||||||||
Adjusted Cost of Revenue(2) | 84,067 | 91,338 | 93,256 | ||||||||||||||
Adjusted Gross Profit | $ | 18,792 | $ | 20,394 | $ | 15,099 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 12, 2026 | Showing above |
| 2024 | Feb 26, 2025 | |
| 2023 | Feb 22, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Mar 1, 2022 | |
| 2020 | Feb 25, 2021 | |
| 2019 | Feb 28, 2020 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.